Cost-effectiveness of artemisinin-based combination therapies for first-line treatment of malaria among pediatric and adult populations: a systematic review protocol
JBI Evidence Synthesis · 2026-10 · 24 (10) · 2138-2147
DOI: 10.11124/jbies-25-00243 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JBI Evidence Synthesis, online erschienen am 11.05.2026. Verfasst von Bindu Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmacy, MS Ramaiah University of Applied Sciences, Bengaluru, India. Hauptthemen laut MEDLINE: Antimalarials, Artemisinins, Malaria, Malaria, Falciparum. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objective
This systematic review will aim to evaluate the evidence on the cost-effectiveness of artemisinin-based combination therapies (ACTs) when used as a first-line treatment for malaria.
Introduction
ACTs have become the World Health Organization’s recommended first-line treatment for uncomplicated Plasmodium falciparum malaria due to their efficacy. Economic constraints in endemic regions necessitate the assessment of their cost-effectiveness. Eligibility criteria: Studies will be eligible if they report on the cost-effectiveness or cost-utility of ACTs and non-ACT or different ACT dose regimens as first-line treatments for malaria among pediatric and adult populations. Methodology: This review will follow the JBI methodology for systematic reviews of economic evidence. PubMed was used to conduct a preliminary search using MeSH terms such as malaria , artemisinin combination therapy, non-artemisinin combination therapy, and cost-effectiveness. This initial search strategy will be adapted to other academic and non-academic databases as well as gray literature. Two reviewers will independently screen records at the title/abstract and full-text levels, with disagreements resolved by a third reviewer. Two reviewers will then conduct a methodological quality assessment and extract data in accordance with JBI guidelines. A summary and comparison of the included studies will be based on the JBI Dominance Ranking Matrix for economic evaluations. The measures of cost-effectiveness/cost-utility will consist of the incremental cost-effectiveness ratio (ICER), the ICER per disability-adjusted life year averted, or the quality-adjusted life years gained. The GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) approach will be used to appraise the certainty of economic evidence. Review registration: PROSPERO CRD420251058688.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, Faculty of Pharmacy, MS Ramaiah University of Applied Sciences, Bengaluru, India.
- Faculty of Pharmacy, MS Ramaiah University of Applied Sciences, Bengaluru, India.
- Department of Public Health Dentistry, Amrita School of Dentistry, Amrita Vishwa Vidyapeetham, Kochi, India.
- JBI Amrita Centre for Evidence-Based Oral Health, Amrita School of Dentistry, Amrita Vishwa Vidyapeetham, Amrita, India.
- Faculty of Life and Allied Health Sciences, MS Ramaiah University of Applied Sciences, Bengaluru, India.
ORCID-Profile: Saraswathy Gr, Chandrasekhar Janakiram
Zitieren
APA
Ma, B., Kr, S., Jith, A., Gr, S., Janakiram, C., & John, D. (2026). Cost-effectiveness of artemisinin-based combination therapies for first-line treatment of malaria among pediatric and adult populations: a systematic review protocol. JBI Evidence Synthesis, 24(10), 2138-2147. https://doi.org/10.11124/jbies-25-00243
Vancouver
Ma B, Kr S, Jith A, Gr S, Janakiram C, John D. Cost-effectiveness of artemisinin-based combination therapies for first-line treatment of malaria among pediatric and adult populations: a systematic review protocol. JBI Evidence Synthesis. 2026;24(10):2138-2147. doi:10.11124/jbies-25-00243
BibTeX
@article{Ma2026,
author = {Ma, Bindu and Kr, Spoorthi and Jith, Akhil and Gr, Saraswathy and Janakiram, Chandrasekhar and John, Denny},
title = {Cost-effectiveness of artemisinin-based combination therapies for first-line treatment of malaria among pediatric and adult populations: a systematic review protocol},
journal = {JBI Evidence Synthesis},
year = {2026},
volume = {24},
number = {10},
pages = {2138--2147},
doi = {10.11124/jbies-25-00243}
}
EUVIMED